Diet quality, PCSK9 inhibitor use, and plasma lipids among adults with heterozygous familial hypercholesterolemia: a cross-sectional study.
Journal of Clinical Lipidology · 2026-11
DOI: 10.1016/j.jacl.2026.11.016 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Clinical Lipidology, 2026-11. Verfasst von Antoine Caron und 6 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Foundation for Dietetic Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Canadian Foundation for Dietetic Research
Zitieren
APA
Caron, A., Desjardins, C., Guay, V., Rancourt-Bouchard, M., Couture, P., Gangloff, A., & Drouin-Chartier, J. (2026). Diet quality, PCSK9 inhibitor use, and plasma lipids among adults with heterozygous familial hypercholesterolemia: a cross-sectional study. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2026.11.016
Vancouver
Caron A, Desjardins C, Guay V, Rancourt-Bouchard M, Couture P, Gangloff A, et al. Diet quality, PCSK9 inhibitor use, and plasma lipids among adults with heterozygous familial hypercholesterolemia: a cross-sectional study. Journal of Clinical Lipidology. 2026. doi:10.1016/j.jacl.2026.11.016
BibTeX
@article{Caron2026,
author = {Caron, Antoine and Desjardins, Clémence and Guay, Valérie and Rancourt-Bouchard, Maryka and Couture, Patrick and Gangloff, Anne and Drouin-Chartier, Jean-Philippe},
title = {Diet quality, PCSK9 inhibitor use, and plasma lipids among adults with heterozygous familial hypercholesterolemia: a cross-sectional study},
journal = {Journal of Clinical Lipidology},
year = {2026},
doi = {10.1016/j.jacl.2026.11.016}
}
EUVIMED